Skandinaviska Enskilda Banken (SEB)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.1M | Sell |
72,390
-70,371
| -49% | -$8.84M | 0.04% | 307 |
|
2025
Q1 | $15.8M | Sell |
142,761
-37,645
| -21% | -$4.16M | 0.08% | 209 |
|
2024
Q4 | $24.7M | Sell |
180,406
-123,436
| -41% | -$16.9M | 0.11% | 151 |
|
2024
Q3 | $35M | Buy |
303,842
+184,005
| +154% | +$21.2M | 0.16% | 112 |
|
2024
Q2 | $16.5M | Buy |
119,837
+2,877
| +2% | +$396K | 0.08% | 196 |
|
2024
Q1 | $16.1M | Buy |
116,960
+54,419
| +87% | +$7.51M | 0.08% | 209 |
|
2023
Q4 | $8.24M | Buy |
62,541
+22,559
| +56% | +$2.97M | 0.05% | 290 |
|
2023
Q3 | $4.5M | Sell |
39,982
-86,335
| -68% | -$9.71M | 0.03% | 377 |
|
2023
Q2 | $11.9M | Sell |
126,317
-58,378
| -32% | -$5.51M | 0.08% | 232 |
|
2023
Q1 | $18.7M | Buy |
184,695
+29,574
| +19% | +$2.99M | 0.13% | 171 |
|
2022
Q4 | $18.5M | Sell |
155,121
-1,663
| -1% | -$199K | 0.14% | 164 |
|
2022
Q3 | $16.7M | Buy |
156,784
+4,233
| +3% | +$450K | 0.13% | 155 |
|
2022
Q2 | $14.9M | Sell |
152,551
-2,702
| -2% | -$263K | 0.11% | 186 |
|
2022
Q1 | $14.6M | Buy |
155,253
+1,633
| +1% | +$153K | 0.09% | 212 |
|
2021
Q4 | $13M | Sell |
153,620
-114
| -0.1% | -$9.65K | 0.07% | 245 |
|
2021
Q3 | $14.7M | Sell |
153,734
-380
| -0.2% | -$36.4K | 0.08% | 231 |
|
2021
Q2 | $15M | Buy |
154,114
+16,585
| +12% | +$1.61M | 0.09% | 214 |
|
2021
Q1 | $13.4M | Buy |
137,529
+81,715
| +146% | +$7.95M | 0.09% | 223 |
|
2020
Q4 | $5.35M | Sell |
55,814
-356
| -0.6% | -$34.1K | 0.04% | 352 |
|
2020
Q3 | $5.4M | Buy |
56,170
+10,770
| +24% | +$1.04M | 0.04% | 322 |
|
2020
Q2 | $5.54M | Buy |
45,400
+6,000
| +15% | +$732K | 0.04% | 308 |
|
2020
Q1 | $3.41M | Sell |
39,400
-13,900
| -26% | -$1.2M | 0.03% | 355 |
|
2019
Q4 | $5.73M | Buy |
53,300
+5,900
| +12% | +$634K | 0.05% | 300 |
|
2019
Q3 | $4.27M | Sell |
47,400
-8,000
| -14% | -$721K | 0.04% | 350 |
|
2019
Q2 | $4.68M | Buy |
+55,400
| New | +$4.68M | 0.04% | 322 |
|